Tapewire

NYSE · USD

UNH

UNITEDHEALTH GROUP INC

Export transactions ↓
Tapewire entity
2809
SEC CIK
0000731766
Parsed reports
3,134

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2021 Filed Feb 24, 2021 22:08 UTC
LEWIS PATRICIA LEVP and Chief HR Officer
GrantCommon Stock 2,862 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-013885 · doc4.xml · nonDerivative · entry 1

LEWIS PATRICIA L · CIK 0001809858 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,575.78

F1 · shares: The restricted stock units vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:10 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
GrantNon-Qualified Stock Options (right to buy) · Derivative 40,703 $0.00 Strike: $327.64 $0.00
Disclosure

SEC source: 0001209191-21-013888 · doc4.xml · derivative · entry 4

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,703

Underlying: Common Stock · 40,703 shares

Expires 2031-02-22

F4 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:10 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
GrantCommon Stock 8,699 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-013888 · doc4.xml · nonDerivative · entry 3

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,751.03

F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:10 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
Tax withholdingCommon Stock 8,410 $327.64 $2,755,452.40
Disclosure

SEC source: 0001209191-21-013888 · doc4.xml · nonDerivative · entry 2

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,052.03

F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:10 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
GrantCommon Stock 18,444 $327.64 $6,042,992.16
Disclosure

SEC source: 0001209191-21-013888 · doc4.xml · nonDerivative · entry 1

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,462.03

F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:11 UTC
REX JOHN FEVP Chief Financial Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 40,703 $0.00 Strike: $327.64 $0.00
Disclosure

SEC source: 0001209191-21-013890 · doc4.xml · derivative · entry 5

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,703

Underlying: Common Stock · 40,703 shares

Expires 2031-02-22

F4 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:11 UTC
REX JOHN FEVP Chief Financial Officer
GrantCommon Stock 8,699 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-013890 · doc4.xml · nonDerivative · entry 3

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,622.668

F3 · shares: The restricted stock units vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:11 UTC
REX JOHN FEVP Chief Financial Officer
Tax withholdingCommon Stock 8,250 $327.64 $2,703,030.00
Disclosure

SEC source: 0001209191-21-013890 · doc4.xml · nonDerivative · entry 2

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,923.668

F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:11 UTC
REX JOHN FEVP Chief Financial Officer
GrantCommon Stock 16,768 $327.64 $5,493,867.52
Disclosure

SEC source: 0001209191-21-013890 · doc4.xml · nonDerivative · entry 1

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,173.668

F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:15 UTC
ROOS THOMAS EChief Accounting Officer
GrantNon-Qualified Stock Options (right to buy) · Derivative 14,282 $0.00 Strike: $327.64 $0.00
Disclosure

SEC source: 0001209191-21-013895 · doc4.xml · derivative · entry 2

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,282

Underlying: Common Stock · 14,282 shares

Expires 2031-02-22

F2 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:15 UTC
ROOS THOMAS EChief Accounting Officer
GrantCommon Stock 3,053 $327.64 $1,000,284.92
Disclosure

SEC source: 0001209191-21-013895 · doc4.xml · nonDerivative · entry 1

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,259.476

F1 · shares: The restricted stock units vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:14 UTC Tax withholdingCommon Stock 13,785 $327.64 $4,516,517.40
Disclosure

SEC source: 0001209191-21-013894 · doc4.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 977,622.019

F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:14 UTC GrantCommon Stock 30,182 $327.64 $9,888,830.48
Disclosure

SEC source: 0001209191-21-013894 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 991,407.019

F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:16 UTC
WITTY ANDREWDirector · CEO, UHG and CEO, Optum
GrantNon-Qualified Stock Options (right to buy) · Derivative 51,325 $0.00 Strike: $327.64 $0.00
Disclosure

SEC source: 0001209191-21-013898 · doc4.xml · derivative · entry 4

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG and CEO, Optum

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,325

Underlying: Common Stock · 51,325 shares

Expires 2031-02-22

F4 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:16 UTC
WITTY ANDREWDirector · CEO, UHG and CEO, Optum
GrantCommon Stock 10,969 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-013898 · doc4.xml · nonDerivative · entry 3

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG and CEO, Optum

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,561.208

F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 22 from the years 2022 through 2025.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:16 UTC
WITTY ANDREWDirector · CEO, UHG and CEO, Optum
Tax withholdingCommon Stock 12,276 $327.64 $4,022,108.64
Disclosure

SEC source: 0001209191-21-013898 · doc4.xml · nonDerivative · entry 2

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG and CEO, Optum

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,592.208

F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:16 UTC
WITTY ANDREWDirector · CEO, UHG and CEO, Optum
GrantCommon Stock 26,119 $327.64 $8,557,629.16
Disclosure

SEC source: 0001209191-21-013898 · doc4.xml · nonDerivative · entry 1

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG and CEO, Optum

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,868.208

F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2018-2020.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 22:37 UTC SaleCommon Stock 1,250 $329.07 $411,336.88
Disclosure

SEC source: 0001209191-21-012821 · doc4.xml · nonDerivative · entry 3

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Partnership

Disclosed balance after: 1,326,500

F3 · shares: This transaction was executed in multiple trades ranging from $329.00 to 329.12 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

F3 · price: This transaction was executed in multiple trades ranging from $329.00 to 329.12 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 22:37 UTC SaleCommon Stock 1,250 $327.36 $409,194.50
Disclosure

SEC source: 0001209191-21-012821 · doc4.xml · nonDerivative · entry 2

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Partnership

Disclosed balance after: 1,327,750

F2 · shares: This transaction was executed in multiple trades ranging from $327.30 to $327.47 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · price: This transaction was executed in multiple trades ranging from $327.30 to $327.47 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 22:37 UTC SaleCommon Stock 2,500 $326.99 $817,463.75
Disclosure

SEC source: 0001209191-21-012821 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Partnership

Disclosed balance after: 1,329,000

F1 · shares: This transaction was executed in multiple trades ranging from $326.90 to $327.23 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

F1 · price: This transaction was executed in multiple trades ranging from $326.90 to $327.23 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 21:58 UTC
ROOS THOMAS EChief Accounting Officer
SaleCommon Stock 864 $327.36 $282,839.04
Disclosure

SEC source: 0001209191-21-011330 · doc4.xml · nonDerivative · entry 1

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,206.476

F1 · shares: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 23, 2020.

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:40 UTC Tax withholdingCommon Stock 1,126 $328.24 $369,598.24
Disclosure

SEC source: 0001209191-21-010868 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 961,225.019

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:41 UTC
LEWIS PATRICIA LEVP and Chief HR Officer
Tax withholdingCommon Stock 232 $328.24 $76,151.68
Disclosure

SEC source: 0001209191-21-010869 · doc4.xml · nonDerivative · entry 1

LEWIS PATRICIA L · CIK 0001809858 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,713.78

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:41 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
Tax withholdingCommon Stock 678 $328.24 $222,546.72
Disclosure

SEC source: 0001209191-21-010872 · doc4.xml · nonDerivative · entry 2

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,018.03

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:41 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
Tax withholdingCommon Stock 508 $328.24 $166,745.92
Disclosure

SEC source: 0001209191-21-010872 · doc4.xml · nonDerivative · entry 1

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,696.03

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:42 UTC
REX JOHN FEVP Chief Financial Officer
Tax withholdingCommon Stock 932 $328.24 $305,919.68
Disclosure

SEC source: 0001209191-21-010874 · doc4.xml · nonDerivative · entry 2

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,405.668

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:42 UTC
REX JOHN FEVP Chief Financial Officer
Tax withholdingCommon Stock 712 $328.24 $233,706.88
Disclosure

SEC source: 0001209191-21-010874 · doc4.xml · nonDerivative · entry 1

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,337.668

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:43 UTC
ROOS THOMAS EChief Accounting Officer
Tax withholdingCommon Stock 383 $328.24 $125,715.92
Disclosure

SEC source: 0001209191-21-010875 · doc4.xml · nonDerivative · entry 2

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,070.476

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:43 UTC
ROOS THOMAS EChief Accounting Officer
Tax withholdingCommon Stock 455 $328.24 $149,349.20
Disclosure

SEC source: 0001209191-21-010875 · doc4.xml · nonDerivative · entry 1

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,453.476

Read SEC document
February 12, 2021 Filed Feb 16, 2021 22:44 UTC
WITTY ANDREWDirector · CEO, UHG and CEO, Optum
Tax withholdingCommon Stock 1,058 $328.24 $347,277.92
Disclosure

SEC source: 0001209191-21-010876 · doc4.xml · nonDerivative · entry 1

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG and CEO, Optum

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,749.208

Read SEC document
February 11, 2021 Filed Feb 16, 2021 22:39 UTC SaleCommon Stock 5,000 $335.80 $1,678,992.00
Disclosure

SEC source: 0001209191-21-010866 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Partnership

Disclosed balance after: 1,331,500

F1 · price: This transaction was executed in multiple trades ranging from $335.3969 to 336.2000 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 22:42 UTC
ROOS THOMAS EChief Accounting Officer
SaleCommon Stock 619 $323.90 $200,494.10
Disclosure

SEC source: 0001209191-21-009815 · doc4.xml · nonDerivative · entry 1

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,908.476

F1 · shares: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 23, 2020.

Read SEC document
February 08, 2021 Filed Feb 9, 2021 22:47 UTC Tax withholdingCommon Stock 1,530 $324.34 $496,240.20
Disclosure

SEC source: 0001209191-21-008907 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 962,351.019

Read SEC document
February 08, 2021 Filed Feb 9, 2021 22:47 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
Tax withholdingCommon Stock 528 $324.34 $171,251.52
Disclosure

SEC source: 0001209191-21-008908 · doc4.xml · nonDerivative · entry 1

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,204.03

Read SEC document
February 08, 2021 Filed Feb 9, 2021 22:48 UTC
REX JOHN FEVP Chief Financial Officer
Tax withholdingCommon Stock 1,024 $324.34 $332,124.16
Disclosure

SEC source: 0001209191-21-008910 · doc4.xml · nonDerivative · entry 1

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,049.668

Read SEC document
February 08, 2021 Filed Feb 9, 2021 22:48 UTC
ROOS THOMAS EChief Accounting Officer
Tax withholdingCommon Stock 625 $324.34 $202,712.50
Disclosure

SEC source: 0001209191-21-008911 · doc4.xml · nonDerivative · entry 1

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,527.476

F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 22:46 UTC PurchaseCommon Stock 1,500 $332.68 $499,025.85
Disclosure

SEC source: 0001209191-21-008905 · doc4.xml · nonDerivative · entry 1

FLYNN TIMOTHY PATRICK · CIK 0001550322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,972

Read SEC document
January 05, 2021 Filed Jan 6, 2021 22:38 UTC
SHORT MARIANNE DEVP & Chief Legal Officer
SaleCommon Stock 9,993 $348.69 $3,484,459.17
Disclosure

SEC source: 0001209191-21-002288 · doc4.xml · nonDerivative · entry 3

SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,756.099

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/16/2020.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:38 UTC GrantCommon Stock 147 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002287 · doc4.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,702

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:38 UTC
SHORT MARIANNE DEVP & Chief Legal Officer
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 39,213 $0.00 Strike: $111.16 $0.00
Disclosure

SEC source: 0001209191-21-002288 · doc4.xml · derivative · entry 4

SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,213 shares

Expires 2026-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The non-qualified stock options vested at a rate of 25% annually on February 9 from the years 2017 through 2020.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:38 UTC
SHORT MARIANNE DEVP & Chief Legal Officer
Tax withholdingCommon Stock 24,222 $351.45 $8,512,821.90
Disclosure

SEC source: 0001209191-21-002288 · doc4.xml · nonDerivative · entry 2

SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,749.099

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/16/2020.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:38 UTC
SHORT MARIANNE DEVP & Chief Legal Officer
Exercise / conversionCommon Stock 39,213 $111.16 $4,358,917.08
Disclosure

SEC source: 0001209191-21-002288 · doc4.xml · nonDerivative · entry 1

SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,971.099

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/16/2020.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:39 UTC GrantCommon Stock 254 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002290 · doc4.xml · nonDerivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,722

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:39 UTC GrantCommon Stock 237 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002291 · doc4.xml · nonDerivative · entry 1

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,348

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:40 UTC GrantCommon Stock 192 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002292 · doc4.xml · nonDerivative · entry 1

MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,914

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:41 UTC GrantCommon Stock 237 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002294 · doc4.xml · nonDerivative · entry 1

MCNABB FREDERICK WILLIAM III · CIK 0001731814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,088

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:41 UTC GrantCommon Stock 147 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002295 · doc4.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,022

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:41 UTC GrantCommon Stock 394 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002296 · doc4.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 963,881.019

F2 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:42 UTC GrantCommon Stock 251 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002297 · doc4.xml · nonDerivative · entry 1

FLYNN TIMOTHY PATRICK · CIK 0001550322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,472

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:42 UTC GrantCommon Stock 147 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-002298 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,953

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.